SCHEMBL5220368

SCHEMBL5220368

Cc1ccc(S(=O)(=O)NC(NS(=O)(=O)c2ccc(C)cc2)C(=O)NCc2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
ATM Q13315 1/20 0.58
CA9 Q16790 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 2/20 0.55
PSMB8 P28062 1/20 0.55
PSMB5 P28074 1/20 0.55
MEN1 O00255 2/20 0.55
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
HSD17B10 Q99714 1/20 0.53
HTT P42858 2/20 0.53
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
LMNA P02545 1/20 0.51
GAA P10253 1/20 0.50
PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7355069 0.86 PSMB5 (0.60) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL3826791 0.85 PSMB5 (0.59) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL5186630 0.79 ALDH1A1 (0.75) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL5221010 0.78 LMNA (0.55) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL16213020 0.77 KMT2A (0.56) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL10076138 0.77 MMP2 (0.54) KMT2AMAPTPSMB8PSMB5ALDH1A1
SCHEMBL16221473 0.76 L3MBTL1 (0.56) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL27721615 0.76 ALDH1A1 (0.58) CYP1A2CYP3A4KMT2AMAPTMEN1
SCHEMBL13800952 0.76 MAPT (0.70) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL7639214 0.76 KMT2A (0.65) CA12CYP1A2CYP3A4ATMCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740549-A2 NOVEL IMIDAZOLES Warner-Lambert Company LLC (US) 2007-01-10 EP disclosed
US-20060287378-A1 Novel pyrroles and imidazoles WARNER-LAMBERT COMPANY LLC 2006-12-21 US disclosed
WO-2005105079-A2 NOVEL IMIDAZOLES WARNER-LAMBERT COMPANY LLC (US) 2005-11-10 WO disclosed
US-20050239857-A1 Novel imidazoles BOLTON GARY L 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287378-A1 Novel pyrroles and imidazoles PPIP5K2, PPIE, PPOX CA12 4451/4885CYP1A2 617/4885CYP3A4 295/4885
US-20050239857-A1 Novel imidazoles HMGCR, HMGB2, HMGB3 CA12 4752/4885CYP1A2 78/4885CYP3A4 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.